financetom
Business
financetom
/
Business
/
BRIEF-HW Electro Files For U.S. IPO - SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BRIEF-HW Electro Files For U.S. IPO - SEC Filing
Apr 29, 2024 3:37 AM

April 29 (Reuters) - HW Electro:

* HW ELECTRO CO., LTD FILES FOR U.S. IPO - SEC FILING

Source text for Eikon:

([email protected])

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Colombia's Ecopetrol to buy back $1.25 bln bond, issue more debt
Colombia's Ecopetrol to buy back $1.25 bln bond, issue more debt
Oct 11, 2024
Oct 8 (Reuters) - Colombia's state-run oil company oil Ecopetrol said on Tuesday it was launching on offer to buy back a bond worth $1.25 billion maturing in 2026, funded though the simultaneous issue of new bonds. ...
Airlines cancel flights, airports close as Florida braces for Hurricane Milton
Airlines cancel flights, airports close as Florida braces for Hurricane Milton
Oct 11, 2024
(Reuters) - U.S. airlines are canceling flights and adjusting schedules as some Florida airports close in anticipation of disruptions from Hurricane Milton, which is set to make landfall in the state on Wednesday. As of Tuesday afternoon, 896 flights within, into, or out of the United States were delayed, and 696 were canceled, with that number expected to rise as...
Accolade Shares Rise After Fiscal Q2 Net Loss Narrows, Revenue Rises; Sets Q3 Guidance, Reiterates 2025 Outlook
Accolade Shares Rise After Fiscal Q2 Net Loss Narrows, Revenue Rises; Sets Q3 Guidance, Reiterates 2025 Outlook
Oct 11, 2024
12:56 PM EDT, 10/08/2024 (MT Newswires) -- Accolade's (ACCD) shares were up more than 7% in recent trading on Tuesday after the company reported a fiscal Q2 net loss of $0.30 per diluted share, narrower than a loss of $0.43 a year earlier. Analysts polled by Capital IQ expected a loss of $0.44. Revenue for the quarter ended Aug. 31...
Update: PTC Therapeutics Reports 'Positive' Updates on Neurodegenerative Disorder Treatment Candidate; Shares Jump
Update: PTC Therapeutics Reports 'Positive' Updates on Neurodegenerative Disorder Treatment Candidate; Shares Jump
Oct 11, 2024
01:07 PM EDT, 10/08/2024 (MT Newswires) -- (Updates with the latest stock move in the last paragraph.) PTC Therapeutics ( PTCT ) said Tuesday that two long-term extension studies of vatiquinone, intended for the treatment of a rare neurodegenerative disorder called Friedreich ataxia, yielded statistically significant results. According to the company, the pre-specified endpoint for the two long-term extension studies...
Copyright 2023-2026 - www.financetom.com All Rights Reserved